- Vaccine efficacy for Pfizer shows a greater decline in men and those with immunosuppression over a period of 6 months. Vaccine efficacy also declines more rapidly in those above 65 years of age. https://www.nejm.org/doi/10.1056/nejmoa2114583 58 comments science
Linking pages
- mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants | Scientific Reports https://www.nature.com/articles/s41598-022-06629-2 1849 comments
- BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2115624 69 comments
- Pfizer Covid-19 vaccine: Studies confirm waning immunity from vaccine | CNN https://www.cnn.com/2021/10/06/health/pfizer-vaccine-waning-immunity/index.html 54 comments
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2118946 18 comments
- Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2200674 8 comments
Linked pages
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2101765?query=featured_home 528 comments
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2109072 56 comments
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2035389 18 comments
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208822 0 comments
Related searches:
Search whole site: site:www.nejm.org
Search title: Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months | NEJM
See how to search.